HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/3/F622    most recent 00427.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Xia, C.-F. Articles by Chao, J. Search for Related Content PubMed PubMed Citation Articles by Xia, C.-F. Articles by Chao, J.

Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina

Submitted 3 December 2004 ; accepted in final form 4 May 2005

In DOCA-salt hypertension, renal kallikrein levels are increased and may play a protective role in renal injury. We investigated the effect of enhanced kallikrein levels on kidney remodeling of DOCA-salt hypertensive rats by systemic delivery of adenovirus containing human tissue kallikrein gene. Recombinant human kallikrein was detected in the urine and serum of rats after gene delivery. Kallikrein gene transfer significantly decreased DOCA- and salt-induced proteinuria, glomerular sclerosis, tubular dilatation, and luminal protein casts. Sirius red staining showed that kallikrein gene transfer reduced renal fibrosis, which was confirmed by decreased collagen I and fibronectin levels. Furthermore, kallikrein gene delivery diminished myofibroblast accumulation in the interstitium of the cortex and medulla, as well as transforming growth factor (TGF)-1 immunostaining in glomeruli. Western blot analysis and ELISA verified the decrease in immunoreactive TGF-1 levels. Kallikrein gene transfer also significantly reduced kidney weight, glomerular size, proliferating tubular epithelial cells, and macrophages/monocytes. Reduction of proliferation and hypertrophy was associated with reduced levels of the cyclin-dependent kinase inhibitor p27^Kip1, and the phosphorylation of c-Jun NH₂-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK). The protective effects of kallikrein were accompanied by increased urinary nitrate/nitrite and cGMP levels, and suppression of superoxide formation. These results indicate that kallikrein protects against mineralocorticoid-induced renal fibrosis glomerular hypertrophy, and renal cell proliferation via inhibition of oxidative stress, JNK/ERK activation, and p27^Kip1 and TGF-1 expression.

transforming growth factor-1; oxidative stress; nitric oxide; mitogen-activated protein kinase

This article has been cited by other articles:

				A. Jadhav, E. Torlakovic, and J. F. Ndisang Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats Am J Physiol Renal Physiol, March 1, 2009; 296(3): F521 - F534. [Abstract] [Full Text] [PDF]

				F. Yi, M. Xia, N. Li, C. Zhang, L. Tang, and P.-L. Li Contribution of Guanine Nucleotide Exchange Factor Vav2 to Hyperhomocysteinemic Glomerulosclerosis in Rats Hypertension, January 1, 2009; 53(1): 90 - 96. [Abstract] [Full Text] [PDF]

				M. Hagiwara, G. Bledsoe, Z.-R. Yang, R. S. Smith Jr., L. Chao, and J. Chao Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1735 - F1743. [Abstract] [Full Text] [PDF]

				G. Bledsoe, B. Shen, Y.-Y. Yao, M. Hagiwara, B. Mizell, M. Teuton, D. Grass, L. Chao, and J. Chao Role of Tissue Kallikrein in Prevention and Recovery of Gentamicin-Induced Renal Injury Toxicol. Sci., April 1, 2008; 102(2): 433 - 443. [Abstract] [Full Text] [PDF]